

A decade ago, the federal government launched its large-scale Medicare Access and CHIP Reauthorization Act (MACRA) in an attempt to move more physicians into value-based care to rein in exploding costs and improve care.
Later this summer, Medical Economics will release the second edition of Medical Economics Insider featuring an in-depth look at how successful MACRA has been and what the future of value-based care looks like, both from the government and from private payers. As part of that extended coverage, we are featuring an advanced look at some of the experts we talked to, offering additional insights into value-based care and what doctors need to know moving forward.
Medical Economics spoke with Mark McClellan, MD, PhD, director, Duke-Margolis Institute for Health Policy, and a former administrator at CMS, about why value-based care hasn’t been adopted more quickly.